Cart
sales@molnova.com
Edralbrutinib
CAS No. 1858206-58-2
Edralbrutinib( —— )
Catalog No. M35710 CAS No. 1858206-58-2
Edralbrutinib (TG-1701) is a potent BTK inhibitor with anticancer activity used in treating tumors, immune system disorders, and blood and lymphatic system disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 299 | Get Quote |
|
| 5MG | 464 | Get Quote |
|
| 10MG | 748 | Get Quote |
|
| 25MG | 1214 | Get Quote |
|
| 50MG | 1638 | Get Quote |
|
| 100MG | 2151 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameEdralbrutinib
-
NoteResearch use only, not for human use.
-
Brief DescriptionEdralbrutinib (TG-1701) is a potent BTK inhibitor with anticancer activity used in treating tumors, immune system disorders, and blood and lymphatic system disorders.
-
DescriptionEdralbrutinib (TG-1701) is a potent BTK inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetBTK
-
RecptorBTK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1858206-58-2
-
Formula Weight489.47
-
Molecular FormulaC26H21F2N5O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C2=C(C(=CN2[C@H]3CN(C(C#CC)=O)CC3)C4=CC=C(OC5=C(F)C=CC=C5F)C=C4)C(N)=NN1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. JIANGSU HENGRUI MEDICINE CO, et al. Pharmaceutically acceptable salt and crystal form of pyrrolo[2,3-d]pyridazin-7-one derivative and preparation method of medicinal salt and crystal form. WO2018210296A1.
molnova catalog
related products
-
ONO-4059 analog
A highly potent and selective Btk inhibitor with IC50 in the sub-nM range; analog of ONO-4059.
-
TAK-020
TAK-020 is a potent covalent inhibitor of Btk with potential antitumor activity for the study of rheumatoid arthritis and immune-related diseases.
-
Tolebrutinib
Tolebrutinib is a potent, selective, orally active and brain-penetrant Bruton tyrosine kinase (BTK) inhibitor(IC50s of 0.4 and 0.7 nM in Ramos B cells and in HMC microglia cells, respectively).
